State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center of Diagnosis and Treatment of Infectious Diseases, National Institute of Communicable Disease Control and Prevention, Chinese Center of Disease Control and Prevention, Beijing, 102206, China.
Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Sci Rep. 2019 Jul 23;9(1):10619. doi: 10.1038/s41598-019-46831-3.
Wildlife is a reservoir of emerging infectious diseases of humans and domestic animals. Marmota himalayana mainly resides 2800-4000 m above sea level in the Qinghai-Tibetan Plateau, and is the primary animal reservoir of plague pathogen Yersinia pestis. Recently we isolated a new species, Escherichia marmotae from the faeces of M. himalayana. In this study we characterised E. marmotae by genomic analysis and in vitro virulence testing to determine its potential as a human pathogen. We sequenced the genomes of the seven E. marmotae strains and found that they contained a plasmid that carried a Shigella-like type III secretion system (T3SS) and their effectors, and shared the same O antigen gene cluster as Shigella dysenterae 8 and E. coli O38. We also showed that E. marmotae was invasive to HEp-2 cells although it was much less invasive than Shigella. Thus E. marmotae is likely to be an invasive pathogen. However, E. marmotae has a truncated IpaA invasin, and lacks the environmental response regulator VirF and the IcsA-actin based intracellular motility, rendering it far less invasive in comparison to Shigella. E. marmotae also carried a diverse set of virulence factors in addition to the T3SS, including an IS1414 encoded enterotoxin gene astA with 37 copies, E. coli virulence genes lifA/efa, cif, and epeA, and the sfp gene cluster, Yersinia T3SS effector yopJ, one Type II secretion system and two Type VI secretion systems. Therefore, E. marmotae is a potential invasive pathogen.
野生动物是人类和家养动物新发传染病的储库。喜马拉雅旱獭主要栖息在青藏高原海拔 2800-4000 米处,是鼠疫病原菌耶尔森氏菌的主要动物宿主。最近,我们从喜马拉雅旱獭的粪便中分离出一种新的物种,即埃希氏菌喜马拉雅亚种。在本研究中,我们通过基因组分析和体外毒力试验对埃希氏菌喜马拉雅亚种进行了特征描述,以确定其作为人类病原体的潜力。我们对 7 株埃希氏菌喜马拉雅亚种的基因组进行了测序,发现它们含有一个质粒,该质粒携带一个类似于志贺氏菌的 III 型分泌系统(T3SS)及其效应子,并且与志贺氏菌 8 型和大肠杆菌 O38 具有相同的 O 抗原基因簇。我们还表明,埃希氏菌喜马拉雅亚种可以侵袭 HEp-2 细胞,尽管其侵袭性远低于志贺氏菌。因此,埃希氏菌喜马拉雅亚种可能是一种侵袭性病原体。然而,埃希氏菌喜马拉雅亚种的 IpaA 入侵素截短,并且缺乏环境响应调节剂 VirF 和基于 IcsA-肌动蛋白的细胞内运动性,使其侵袭性远低于志贺氏菌。埃希氏菌喜马拉雅亚种除了 T3SS 之外,还携带了多种毒力因子,包括一个由 IS1414 编码的肠毒素基因 astA,有 37 个拷贝,大肠杆菌毒力基因 lifA/efa、cif 和 epeA,以及 sfp 基因簇、耶尔森氏菌 T3SS 效应子 yopJ、一个 II 型分泌系统和两个 VI 型分泌系统。因此,埃希氏菌喜马拉雅亚种是一种潜在的侵袭性病原体。